Impact of diagnosis-to-treatment interval in relapsed or refractory diffuse large B-cell lymphoma

Key Points

• Increased diagnosis-to-treatment interval negatively affects outcomes in treated patients.
• Specifically, delayed treatment intervals are linked with poorer overall survival rates.
• Observational analysis reviewed 150 cases of relapsed or refractory diffuse large B-cell lymphoma.
• Prompt treatment initiation may enhance prognosis and warrants further exploration.